Clinical Trial Update: Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) [Phase 3]

View source ↗

Summary

A completed Phase 3 long-term trial evaluating growth hormone deficiency in adults (GHDA) sponsored by Novo Nordisk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 3 | Status: COMPLETED